Zoetis
ZTSS&P 500
73,60 $
Dividend yield2,19 %
Continuity14 yr
Dividend1,59 $
DiviScore
GoodPerformance14/35
Dividend Quality27/35
AGM Date
—Ex-Date
20.07.2026Payment
—CAGR 3Y
-27.1%CAGR 5Y
-18.9%CAGR 10Y
+3.7%€10,000 invested in 2016 · with dividend reinvestment
End Value
15.497,76 $
Total Return
+55.0%
Annual Return
4.5% p.a.
Dividends Received
2.148,15 $
Dividend history
Quarterly Results
About Zoetis
Zoetis is the world's largest animal health company, developing vaccines, medicines and diagnostics for both livestock and companion animals. Spun off from Pfizer, it benefits from resilient demand as pet ownership grows and owners spend more on veterinary care, giving it a steady, less cyclical growth profile. Zoetis has raised its dividend every year since its 2013 listing, growing the payout rapidly from a low base. The yield remains modest because the stock is valued for growth, but the fast, consistent increases and strong cash generation give it an attractive, if currently small, income component.
Frequently Asked Questions
The next payment date is not yet announced.
Zoetis has a DiviScore of 58/100. DiviScore rates dividend stocks based on price performance, dividend quality, fundamentals, and stability.
Zoetis's current dividend yield is 2.19% based on the latest dividend.
Zoetis (ZTS) is a member of S&P 500. Current data including price, dividend, and DiviScore is updated daily.
DiviScore is a proprietary 100-point rating based on four pillars: Performance (35 pts), Dividend Quality (35 pts), Fundamentals (15 pts), and Stability (15 pts). It simulates a 10-year investment with automatic dividend reinvestment.